Novartis AG
NVS
| News
| $88.91
|
|
Health Technology
(0.0% 1d) (3.0% 1m) (-8.2% 1y) (0.0% 2d) (0.0% 3d) (-0.6% 7d) (NaN% volume)
http://www.novartis.com
Sec Filling | Patents | 103914 employees
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
add to today's watch list email alert is off
Press-releases
Insights on the Cardiac Arrest Treatment Global Market to 2026 - Rising Healthcare Expenditure in Emerging Countries Presents Opportunities
Published: 2022-01-21 (Crawled : 15:30) - prnewswire.com
SYK | News | $259.44 |
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
NVS | News | $88.91 |
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
PHG | News | $33.79 |
|
Health Technology
|
| O: -0.95%
H: 0.0%
C: 0.0%
ABT | News | $126.36 |
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
BSX | News | $43.45 |
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
MDT | News | $106.11 |
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
LIVN | News | $81.77 |
|
Health Technology
|
| O: -0.79%
H: 0.0%
C: 0.0%
treatment health cardiac thc
Irritable Bowel Syndrome Market to grow at a CAGR of 10.09% by 2025 |IBS-D Segment to be Significant for Revenue Generation|17000+ Technavio Reports
Published: 2022-01-21 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $121.21 |
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NVS | News | $88.91 |
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
ABBV | News | $134.37 |
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ALPMY | News | $16.71 |
|
Manufacturing
|
| O: -1.74%
H: 3.65%
C: 2.98%
BHC | News | $25.53 |
|
Health Technology
|
| O: -2.86%
H: 0.0%
C: 0.0%
AZN | News | $60.17 |
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
era report
Attention Deficit Hyperactivity Disorder Drugs Market to Record 6.44% Y-O-Y Growth Rate in 2021 |Johnson and Johnson Inc. offers ADHD Drugs namely Concerta Tablets| Technavio
Published: 2022-01-20 (Crawled : 17:00) - prnewswire.com
NVS | News | $88.91 |
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
order era drug adhd growth
Brain Tumor Therapeutics Market to Record 9.10% Y-O-Y Growth Rate in 2021 | Amgen Inc. and Bristol-Myers Squibb Co. Among Key Vendors | Technavio
Published: 2022-01-19 (Crawled : 09:00) - prnewswire.com
NVS | News | $88.91 |
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
GSK | News | $45.14 |
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
NVSEF | News | $88.6 |
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
GLAXF | News | $22.8 |
|
Health Technology
|
| O: -1.71%
H: 0.22%
C: -1.8%
AMGN | $233.73 |
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
era therapeutics growth
Prils Market to grow at a CAGR of 5.43% by 2026 | Evolving Opportunities with Aurobindo Pharma Ltd. and Dr. Reddys Laboratories Ltd.|17000+ Technavio Reports
Published: 2022-01-19 (Crawled : 07:00) - prnewswire.com
NVS | News | $88.91 |
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
NVSEF | News | $88.6 |
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
VTRS | $14.64 |
|
Health Technology
|
| O: -0.79%
H: 0.53%
C: -2.19%
report
Osteoporosis Drugs Market - 38% of Growth to Originate from North America |Antiresorptive Drugs Segment to be Significant for Revenue Generation | 17000+ Technavio Reports
Published: 2022-01-18 (Crawled : 17:00) - prnewswire.com
NVS | News | $88.91 |
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
AMGN | $233.73 |
|
Health Technology
|
| O: 1.4%
H: 0.0%
C: 0.0%
NVSEF | News | $88.6 |
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
america era drug report growth osteoporosis
Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | News | $88.6 |
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
SRNE | $4.45 |
|
Health Technology
|
| O: -5.96%
H: 0.0%
C: 0.0%
NVS | News | $88.91 |
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
GILD | $67.81 |
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
BLUE | $6.93 |
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
JNJ | News | $167.27 |
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
era cel therapy t-cell
41% of Growth to Originate from North America for Microbial Products Market |Evolving Opportunities with bioMerieux SA, GlaxoSmithKline Plc & Kyowa Hakko Bio Co. Ltd. |17000+ Technavio Reports
Published: 2022-01-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News 3 d | $105.0 |
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GSK | News | $45.14 |
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
NVS | News | $88.91 |
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: 0.0%
TMO | $595.43 |
|
Health Technology
|
| O: 0.69%
H: 0.19%
C: -3.81%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
america growth
Global End Stage Renal Disease Market 2021-2027: Low Maintenance Dialysis Equipment and Artificial Kidneys are Expected to Drive Market Growth
Published: 2022-01-11 (Crawled : 17:00) - prnewswire.com
MDT | News | $106.11 |
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
SNY | News 3 d | $52.31 |
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
GLAXF | News | $22.8 |
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
AMGN | $233.73 |
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
NVS | News | $88.91 |
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
SNYNF | News 3 d | $105.0 |
|
Health Technology
|
| O: -3.41%
H: 5.99%
C: 1.1%
GSK | News | $45.14 |
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
BMY | $64.58 |
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
Fluorine-18 Market to Exceed US$ 3 Bn by 2030; Surge in Use of PET/CT Scan in Oncology Spurs Demand for FDGs, Notes Study by TMR
Published: 2022-01-06 (Crawled : 15:00) - prnewswire.com
GE | News | $100.35 |
|
Electronic Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
NVSEF | News | $88.6 |
|
Health Technology
|
| O: -0.1%
H: 0.82%
C: 0.7%
NVS | News | $88.91 |
|
Health Technology
|
| O: 0.75%
H: 0.16%
C: -0.45%
LLY | News | $246.46 |
|
Health Technology
|
| O: -2.81%
H: 0.0%
C: 0.0%
LNTH | $25.86 |
|
Health Technology
|
| O: -1.42%
H: 2.7%
C: 2.11%
ema scan
Last 15 days Sec forms
| File Id | Form | Date | Direction | Code | Amount Transacted | Owned Amount |